ArticleAmerican journal of cancer research2026
Immune checkpoint inhibitors combined with chemotherapy enhance coagulation activation and elevate venous thromboembolism risk in non-small cell lung cancer.
Weihua Song et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.